Go Pro
NASDAQ:ASTC

Astrotech Q2 2025 Earnings Report

Astrotech logo
$6.82 +0.28 (+4.30%)
As of 11:59 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Astrotech EPS Results

Actual EPS
-$2.45
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Astrotech Revenue Results

Actual Revenue
$260.00 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Astrotech Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Astrotech Earnings Headlines

Astrotech (NASDAQ:ASTC) Raised to Sell at Wall Street Zen
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top S&P 500 stock for 12 years running—and today, he's giving away his #1 AI stock pick for 2026, free. This company's sales are up 28% year over year, it holds over 30,000 patents in wireless and video technology, and it just earned an A-rating in his proprietary Stock Grader system that has cost him $9 million to build and maintain.tc pixel
ASTROTECH APPOINTS MATT KREPS TO BOARD OF DIRECTORS
See More Astrotech Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Astrotech? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Astrotech and other key companies, straight to your email.

About Astrotech

Astrotech (NASDAQ:ASTC) Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms. A key milestone was the spin-out of 908 Devices in 2020, a subsidiary that developed portable mass spectrometers for field detection of chemicals and bio-agents. Building on that foundation, Astrotech continues to pursue point-of-care screening technologies for environmental monitoring, food safety and clinical diagnostics.

Through Astrotech Solar and other affiliates, the company is also active in renewable energy commercialization. This segment concentrates on high-efficiency photovoltaic materials and manufacturing processes originally developed in partnership with academic and federal laboratories. By licensing proprietary cell architectures and overseeing pilot-scale production, Astrotech aims to reduce costs and accelerate adoption of clean-energy solutions in global markets.

Founded in 1984 as AIT International, Astrotech has evolved via strategic acquisitions and spin-offs to maintain a diversified technology portfolio. The company collaborates with public-sector agencies, research institutions and industry partners to advance its product pipeline. Astrotech’s leadership brings expertise in engineering, regulatory affairs and business development to guide the firm’s long-term growth and commercialization efforts.

View Astrotech Profile